Viking Pharma (Opc) Private Limited
Founded in 2021 and headquartered in Uttar Pradesh, India.
2021 | Ghaziabad, Uttar Pradesh (India) | Active
Viking Pharma (Opc) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
About Viking Pharma (Opc)
Viking Pharma (Opc) Private Limited (VPOPL) is a Company incorporated in India on 04 January 2021 (Four years and one month 23 days old ). Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Company is engaged in the Home Appliances Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Girish Pandey serves as a director at the Company.
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U52399UP2021OPC139968
- Company No.
139968
- Incorporation Date
04 Jan 2021
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Home Appliances
What products or services does Viking Pharma (Opc) Private Limited offer?
Viking Pharma (Opc) Private Limited offers a wide range of products and services, including Brain & Nervous System Drugs, Antiepileptic Drugs, Antidepressant & Anti Anxiety Medicines, Psychotherapeutic Agents, Pain Relief Drugs & Pharmaceuticals, Muscle Relaxant.
Who are the key members and board of directors at Viking Pharma (Opc)?
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Girish Pandey  | Director | 04-Jan-2021 | Current |
Financial Performance of Viking Pharma (Opc).
Viking Pharma (Opc) Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Viking Pharma (Opc)?
Unlock access to Viking Pharma (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Lusaris Innovations Private LimitedGirish Pandey is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Viking Pharma (Opc)?
Viking Pharma (Opc) has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Viking Pharma (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Viking Pharma (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.